Autotaxin: Its role in biology of melanoma cells and as a pharmacological target

Enzyme Research

Volumn 2011, Issue 1, 2011, Pages

  Jankowski, MacIej ^a,b  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

^b MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

1 ACYL SN GLYCERO 2,3 CYCLIC PHOSPHATE; 1 MYRISTOYL LYSOPHOSPHATIDIC ACID; 1 OLEOYL LYSOPHOSPHATIDIC ACID; 1 OLEOYL SN GLYCERO 2,3 CYCLIC PHOSPHATE; 1 PALMITOLEOYL SN GLYCERO 2,3 CYCLIC PHOSPHATE; 1 PALMITOYL LYSOPHOSPHATIDIC ACID; AUTOTAXIN; G PROTEIN COUPLED RECEPTOR; HEXACHLOROPHENE; HISTIDINE; LIPID; LYSOPHOSPHATIDIC ACID; LYSOPHOSPHATIDIC ACID RECEPTOR; MERBROMIN; PERTUSSIS TOXIN; PF 8380; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; UNCLASSIFIED DRUG;

ANGIOGENESIS; ARTICLE; BIOCHEMISTRY; BODY FLUID; CARCINOGENESIS; CELL INVASION; CELL MATURATION; CELL MIGRATION; CELL MOTILITY; CONCENTRATION RESPONSE; CYTOLOGY; DRUG MECHANISM; DRUG TARGETING; EMBRYO DEVELOPMENT; ENZYME ACTIVITY; ENZYME BINDING; ENZYME INHIBITION; ENZYME MODIFICATION; ENZYME RELEASE; ENZYME STRUCTURE; HUMAN; IC 50; IMMUNE RESPONSE; IN VIVO STUDY; INTRACELLULAR SIGNALING; MELANOMA CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR GROWTH;

EID: 79960362839     PISSN: 20900406     EISSN: 20900414     Source Type: Journal    
DOI: 10.4061/2011/194857     Document Type: Article

References (53)

1. Stefan C., Jansen S., Bollen M., NPP-type ectophosphodiesterases: unity in diversity. Trends in Biochemical Sciences 2005 30 10 542 550 2-s2.0-25144473903 10.1016/j.tibs.2005.08.005 (Pubitemid 41356492)
2. Stracke M. L., Arestad A., Levine M., Krutzsch H. C., Liotta L. A., Autotaxin is an N-linked glycoprotein but the sugar moieties are not needed for its stimulation of cellular motility. Melanoma Research 1995 5 4 203 209 2-s2.0-0029013367
3. Jansen S., Stefan C., Creemers J. W. M., Waelkens E., Van Eynde A., Stalmans W., Bollen M., Proteolytic maturation and activation of autotaxin (NPP2), a secreted metastasis-enhancing lysophospholipase D. Journal of Cell Science 2005 118 14 3081 3089 2-s2.0-23844465897 10.1242/jcs.02438 (Pubitemid 41149912)
4. Yuelling L. M., Fuss B., Autotaxin (ATX): a multi-functional and multi-modular protein possessing enzymatic lysoPLD activity and matricellular properties. Biochimica et Biophysica Acta 2008 1781 9 525 530 2-s2.0-49949092545 10.1016/j.bbalip.2008.04.009
5. Nakanaga K., Hama K., Aoki J., Autotaxin-An LPA producing enzyme with diverse functions. Journal of Biochemistry 2010 148 1 13 24 2-s2.0-77954391618 10.1093/jb/mvq052
6. Van Meeteren L. A., Ruurs P., Christodoulou E., Goding J. W., Takakusa H., Kikuchi K., Perrakis A., Nagano T., Moolenaar W. H., Inhibition of autotaxin by lysophosphatidic acid and sphingosine 1-phosphate. Journal of Biological Chemistry 2005 280 22 21155 21161 2-s2.0-20444386550 10.1074/jbc.M413183200 (Pubitemid 40805676)
7. Sugiura T., Nakane S., Kishimoto S., Waku K., Yoshioka Y., Tokumura A., Lysophosphatidic acid, a growth factor-like lipid, in the saliva. Journal of Lipid Research 2002 43 12 2049 2055 2-s2.0-0036906499 10.1194/jlr.M200242-JLR200 (Pubitemid 35471071)
8. Tanaka M., Kishi Y., Takanezawa Y., Kakehi Y., Aoki J., Arai H., Prostatic acid phosphatase degrades lysophosphatidic acid in seminal plasma. FEBS Letters 2004 571 1-3 197 204 2-s2.0-3342915550 10.1016/j.febslet.2004.06. 083 (Pubitemid 38992948)
9. Masuda A., Nakamura K., Izutsu K., Igarashi K., Ohkawa R., Jona M., Higashi K., Yokota H., Okudaira S., Kishimoto T., Watanabe T., Koike Y., Ikeda H., Kozai Y., Kurokawa M., Aoki J., Yatomi Y., Serum autotaxin measurement in haematological malignancies: a promising marker for follicular lymphoma. British Journal of Haematology 2008 143 1 60 70 2-s2.0-51249116856 10.1111/j.1365-2141. 2008.07325.x
10. Nakamura K., Nangaku M., Ohkawa R., Okubo S., Yokota H., Ikeda H., Aoki J., Yatomi Y., Analysis of serum and urinary lysophospholipase D/autotaxin in nephrotic syndrome. Clinical Chemistry and Laboratory Medicine 2008 46 1 150 151 2-s2.0-38349041878 10.1515/CCLM.2008.025
11. Nakamura K., Igarashi K., Ohkawa R., Okubo S., Yokota H., Kishimoto T., Ide K., Masuda A., Yamamoto T., Saito N., Kurokawa M., Tsuji S., Okudaira S., Ikeda H., Aoki J., Yatomi Y., Autotaxin enzyme immunoassay in human cerebrospinal fluid samples. Clinica Chimica Acta 2009 405 1-2 160 162 2-s2.0-67349125714 10.1016/j.cca.2009.04.025
12. Jansen S., Andries M., Vekemans K., Vanbilloen H., Verbruggen A., Bollen M., Rapid clearance of the circulating metastatic factor autotaxin by the scavenger receptors of liver sinusoidal endothelial cells. Cancer Letters 2009 284 2 216 221 2-s2.0-69549105818 10.1016/j.canlet.2009.04.029
13. Tanaka M., Okudaira S., Kishi Y., Ohkawa R., Iseki S., Ota M., Noji S., Yatomi Y., Aoki J., Arai H., Autotaxin stabilizes blood vessels and is required for embryonic vasculature by producing lysophosphatidic acid. Journal of Biological Chemistry 2006 281 35 25822 25830 2-s2.0-33748757239 10.1074/jbc.M605142200 (Pubitemid 44401970)
14. Alvarez S. E., Milstien S., Spiegel S., Autocrine and paracrine roles of sphingosine-1-phosphate. Trends in Endocrinology and Metabolism 2007 18 8 300 307 2-s2.0-34948813594 10.1016/j.tem.2007.07.005 (Pubitemid 47531961)
15. Fyrst H., Saba J. D., An update on sphingosine-1-phosphate and other sphingolipid mediators. Nature Chemical Biology 2010 6 7 489 497 2-s2.0-77953790503 10.1038/nchembio.392
16. '-nucleotide phosphodiesterase/ATP pyrophosphatase and ATPase activities. Journal of Biological Chemistry 1997 272 2 996 1001 2-s2.0-0031021476 10.1074/jbc.272.2.996 (Pubitemid 27034592)
17. Gijsbers R., Aoki J., Arai H., Bollen M., The hydrolysis of lysophospholipids and nucleotides by autotaxin (NPP2) involves a single catalytic site. FEBS Letters 2003 538 1-3 60 64 2-s2.0-0037434917 10.1016/S0014-5793(03)00133-9 (Pubitemid 36287425)
18. van Meeteren L. A., Moolenaar W. H., Regulation and biological activities of the autotaxin-LPA axis. Progress in Lipid Research 2007 46 2 145 160 2-s2.0-34247534260 10.1016/j.plipres.2007.02.001 (Pubitemid 46654231)
19. Aoki J., Inoue A., Okudaira S., Two pathways for lysophosphatidic acid production. Biochimica et Biophysica Acta 2008 1781 9 513 518 2-s2.0-49949098676 10.1016/j.bbalip.2008.06.005
20. Okudaira S., Yukiura H., Aoki J., Biological roles of lysophosphatidic acid signaling through its production by autotaxin. Biochimie 2010 92 6 698 706 2-s2.0-77953288970 10.1016/j.biochi.2010.04.015
21. Hama K., Bandoh K., Kakehi Y., Aoki J., Arai H., Lysophosphatidic acid (LPA) receptors are activated differentially by biological fluids: possible role of LPA-binding proteins in activation of LPA receptors. FEBS Letters 2002 523 1-3 187 192 2-s2.0-0037125239 10.1016/S0014-5793(02)02976-9 (Pubitemid 34786084)
22. Lee J., Jung IN. D., Nam S. W., Clair T., Jeong E. M., Hong S. Y., Han J. W., Lee H. W., Stracke M. L., Lee H. Y., Enzymatic activation of autotaxin by divalent cations without EF-hand loop region involvement. Biochemical Pharmacology 2001 62 2 219 224 2-s2.0-0035879950 10.1016/S0006-2952(01)00658-X (Pubitemid 32522942)
23. Boutin J. A., Ferry G., Autotaxin. Cellular and Molecular Life Sciences 2009 66 18 3009 3021 2-s2.0-66449095053 10.1007/s00018-009-0056-9
24. Jansen S., Andries M., Derua R., Waelkens E., Bollen M., Domain interplay mediated by an essential disulfide linkage is critical for the activity and secretion of the metastasis-promoting enzyme autotaxin. Journal of Biological Chemistry 2009 284 21 14296 14302 2-s2.0-67649819849 10.1074/jbc.M900790200
25. Koh E., Bandle R. W., Roberts D. D., Stracke M. L., Clair T., Novel point mutations attenuate autotaxin activity. Lipids in Health and Disease 2009 8, article no. 4 2-s2.0-61649097328 10.1186/1476-511X-8-4
26. Van Meeteren L. A., Ruurs P., Stortelers C., Bouwman P., Van Rooijen M. A., Pradère J. P., Pettit T. R., Wakelam M. J. O., Saulnier-Blache J. S., Mummery C. L., Moolenaar W. H., Jonkers J., Autotaxin, a secreted lysophospholipase D, is essential for blood vessel formation during development. Molecular and Cellular Biology 2006 26 13 5015 5022 2-s2.0-33745466418 10.1128/MCB.02419-05 (Pubitemid 43955815)
27. Choi JI. W., Lee C. W., Chun J., Biological roles of lysophospholipid receptors revealed by genetic null mice: an update. Biochimica et Biophysica Acta 2008 1781 9 531 539 2-s2.0-49949116576 10.1016/j.bbalip.2008.03.004
28. Liu S., Umezu-Goto M., Murph M., Lu Y., Liu W., Zhang F., Yu S., Stephens L. C., Cui X., Murrow G., Coombes K., Muller W., Hung M. C., Perou C. M., Lee A. V., Fang X., Mills G. B., Expression of autotaxin and lysophosphatidic acid receptors increases mammary tumorigenesis, invasion, and metastases. Cancer Cell 2009 15 6 539 550 2-s2.0-65649132676 10.1016/j.ccr.2009.03.027
29. Stracke M. L., Krutzsch H. C., Unsworth E. J., Arestad A., Cioce V., Schiffmann E., Liotta L. A., Identification, purification, and partial sequence analysis of autotaxin, a novel motility-stimulating protein. Journal of Biological Chemistry 1992 267 4 2524 2529 2-s2.0-0026787698
30. Umezu-Goto M., Kishi Y., Taira A., Hama K., Dohmae N., Takio K., Yamori T., Mills G. B., Inoue K., Aoki J., Arai H., Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production. Journal of Cell Biology 2002 158 2 227 233 2-s2.0-1542359873
31. Gaetano C. G., Samadi N., Tomsig J. L., Macdonald T. L., Lynch K. R., Brindley D. N., Inhibition of autotaxin production or activity blocks lysophosphatidylcholine-induced migration of human breast cancer and melanoma cells. Molecular Carcinogenesis 2009 48 9 801 809 2-s2.0-70249149314 10.1002/mc.20524
32. Altman M. K., Gopal V., Jia W., Yu S., Hall H., Mills G. B., McGinnis A. C., Bartlett M. G., Jiang G., Madan D., Prestwich G. D., Xu Y., Davies M. A., Murph M. M., Targeting melanoma growth and viability reveals dualistic functionality of the phosphonothionate analogue of carba cyclic phosphatidic acid. Molecular Cancer 2010 9, article no. 140 2-s2.0-77954312353 10.1186/1476-4598-9-140
33. Singh A. D., Sisley K., Xu Y., Li J., Faber P., Plummer S. J., Mudhar H. S., Rennie I. G., Kessler P. M., Casey G., Williams B. G., Reduced expression of autotaxin predicts survival in uveal melanoma. British Journal of Ophthalmology 2007 91 10 1385 1392 2-s2.0-34848849062 10.1136/bjo.2007.116947 (Pubitemid 47492881)
34. Hama K., Aoki J., Fukaya M., Kishi Y., Sakai T., Suzuki R., Ohta H., Yamori T., Watanabe M., Chun J., Arai H., Lysophosphatidic acid and autotaxin stimulate cell motility of neoplastic and non-neoplastic cells through LPA. Journal of Biological Chemistry 2004 279 17 17634 17639 2-s2.0-2342437623 10.1074/jbc.M313927200 (Pubitemid 38560528)
35. Lee H. Y., Bae G. U., Jung IN. D., Lee J. S., Kim Y. K., Noh S. H., Stracke M. L., Park C. G., Lee H. W., Han J. W., Autotaxin promotes motility via G protein-coupled phosphoinositide 3-kinase γ in human melanoma cells. FEBS Letters 2002 515 1-3 137 140 2-s2.0-18344370242 10.1016/S0014-5793(02) 02457-2 (Pubitemid 34273912)
36. Jung IN. D., Lee J., Yun S. Y., Park C. G., Choi W. S., Lee H. W., Choi O. H., Han J. W., Lee H. Y., Cdc42 and Rac1 are necessary for autotaxin-induced tumor cell motility in A2058 melanoma cells. FEBS Letters 2002 532 3 351 356 2-s2.0-0037132539 10.1016/S0014-5793(02)03698-0 (Pubitemid 35441372)
37. Jung IN. D., Lee J., Lee K. B., Park C. G., Kim Y. K., Seo D. W., Park D., Lee H. W., Han J. W., Lee H. Y., Activation of p21-activated kinase 1 is required for lysophosphatidic acid-induced focal adhesion kinase phosphorylation and cell motility in human melanoma A2058 cells. European Journal of Biochemistry 2004 271 8 1557 1565 2-s2.0-2142750178 10.1111/j.1432-1033.2004. 04066.x (Pubitemid 38553561)
38. Lee J., Jung I. D., Park C. G., Han J. W., Lee H. Y., Autotaxin stimulates urokinase-type plasminogen activator expression through phosphoinositide 3-kinase-Akt-necrosis factor kappa B signaling cascade in human melanoma cells. Melanoma Research 2006 16 5 445 452 2-s2.0-33749431430 10.1097/01.cmr.0000232293.14408.a4 (Pubitemid 44511225)
39. Gendaszewska-Darmach E., Lysophosphatidic acids, cyclic phosphatidic acids and autotaxin as promissing targets in therapies of cancer and other diseases. Acta Biochimica Polonica 2008 55 2 227 240 2-s2.0-46749147203 (Pubitemid 351947537)
40. Clair T., Koh E., Ptaszynska M., Bandle R. W., Liotta L. A., Schiffmann E., Stracke M. L., L-histidine inhibits production of lysophosphatidic acid by the tumor-associated cytokine, autotaxin. Lipids in Health and Disease 2005 4, article 5 2-s2.0-17844384215 10.1186/1476-511X-4-5 (Pubitemid 40594710)
41. Bakera D. L., Fujiwara Y., Pigg K. R., Tsukahara R., Kobayashi S., Murofushi H., Uchiyama A., Murakami-Murofushi K., Koh E., Bandle R. W., Byun H. S., Bittman R., Fan D., Murph M., Mills G. B., Tigyi G., Carba analogs of cyclic phosphatidic acid are selective inhibitors of autotaxin and cancer cell invasion and metastasis. Journal of Biological Chemistry 2006 281 32 22786 22793 2-s2.0-33747354637 10.1074/jbc.M512486200
42. Prestwich G. D., Gajewiak J., Zhang H., Xu X., Yang G., Serban M., Phosphatase-resistant analogues of lysophosphatidic acid: agonists promote healing, antagonists and autotaxin inhibitors treat cancer. Biochimica et Biophysica Acta 2008 1781 9 588 594 2-s2.0-49949105271 10.1016/j.bbalip.2008.03. 008
43. Uchiyama A., Mukai M., Fujiwara Y., Kobayashi S., Kawai N., Murofushi H., Inoue M., Enoki S., Tanaka Y., Niki T., Kobayashi T., Tigyi G., Murakami-Murofushi K., Inhibition of transcellular tumor cell migration and metastasis by novel carba-derivatives of cyclic phosphatidic acid. Biochimica et Biophysica Acta 2007 1771 1 103 112 2-s2.0-33846066349 10.1016/j.bbalip.2006. 10.001 (Pubitemid 46073879)
44. Jiang G., Xu Y., Fujiwara Y., Tsukahara T., Tsukahara R., Gajewiak J., Tigyi G., Prestwich G. D., α -substituted phosphonate analogues of lysophosphatidic acid (LPA) selectively inhibit production and action of LPA. ChemMedChem 2007 2 5 679 690 2-s2.0-35448975763 10.1002/cmdc.200600280
45. Fujiwara Y., Cyclic phosphatidic acid-a unique bioactive phospholipid. Biochimica et Biophysica Acta 2008 1781 9 519 524 2-s2.0-49949084021 10.1016/j.bbalip.2008.05.002
46. Albers H. M. H. G., Dong A., Van Meeteren L. A., Egan D. A., Sunkara M., Van Tilburg E. W., Schuurman K., Van Tellingen O., Morris A. J., Smyth S. S., Moolenaar W. H., Ovaa H., Boronic acid-based inhibitor of autotaxin reveals rapid turnover of LPA in the circulation. Proceedings of the National Academy of Sciences of the United States of America 2010 107 16 7257 7262 2-s2.0-77952173274 10.1073/pnas.1001529107
47. Gierse J., Thorarensen A., Beltey K., Bradshaw-Pierce E., Cortes-Burgos L., Hall T., Johnston A., Murphy M., Nemirovskiy O., Ogawa S., Pegg L., Pelc M., Prinsen M., Schnute M., Wendling J., Wene S., Weinberg R., Wittwer A., Zweifel B., Masferrer J., A novel autotaxin inhibitor reduces lysophosphatidic acid levels in plasma and the site of inflammation. Journal of Pharmacology and Experimental Therapeutics 2010 334 1 310 317 2-s2.0-77953778656 10.1124/jpet.110.165845
48. Saunders L. P., Ouellette A., Bandle R., Chang W. C., Zhou H., Misra R. N., De La Cruz E. M., Braddock D. T., Identification of small-molecule inhibitors of autotaxin that inhibit melanoma cell migration and invasion. Molecular Cancer Therapeutics 2008 7 10 3352 3362 2-s2.0-55749092457 10.1158/1535-7163.MCT-08-0463
49. Hoeglund A. B., Howard A. L., Wanjala I. W., Pham T. C. T., Parrill A. L., Baker D. L., Characterization of non-lipid autotaxin inhibitors. Bioorganic and Medicinal Chemistry 2010 18 2 769 776 2-s2.0-76449086955 10.1016/j.bmc.2009.11.056
50. Hoeglund A. B., Bostic H. E., Howard A. L., Wanjala I. W., Best M. D., Baker D. L., Parrill A. L., Optimization of a pipemidic acid autotaxin inhibitor. Journal of Medicinal Chemistry 2010 53 3 1056 1066 2-s2.0-77249146942 10.1021/jm9012328
51. Ueda K., Yoshihara M., Nakao M., Tanaka T., Sano S., Fukuzawa K., Tokumura A., Evaluation of inhibitory actions of flavonols and related substances on lysophospholipase D activity of serum autotaxin by a convenient assay using a chromogenic substrate. Journal of Agricultural and Food Chemistry 2010 58 10 6053 6063 2-s2.0-77952643453 10.1021/jf904155a
52. Day J. E., Hall T., Pegg L. E., Benson T. E., Hausmann J., Kamtekar S., satwik.kamtekar@gmail.com Crystallization and preliminary X-ray diffraction analysis of rat autotaxin. Acta Crystallographica Section F 2010 66 9 1127 1129 10.1107/S1744309110030228
53. Hausmann J., Christodoulou E., Kasiem M., De Marco V., Van Meeteren L. A., Moolenaar W. H., Axford D., Owen R. L., Evans G., Perrakis A., a.perrakis@nki.nl Mammalian cell expression, purification, crystallization and microcrystal data collection of autotaxin/ENPP2, a secreted mammalian glycoprotein. Acta Crystallographica Section F 2010 66 9 1130 1135 10.1107/S1744309110032938